Buy & Sell: Accessories > Buy & Sell: Others
ʶҺѹ NIBIOHN ÃèÇÁ¡ÑººÃÔÉÑ· ªÔâÍâ¹¡Ô ¤é¹¾ºá͹µÔºÍ´ÕµéÒ¹äÇÃÑÊâ¤âùҵÑÇãËÁè
(1/1)
PostDD:
ʶҺѹ NIBIOHN ÃèÇÁ¡ÑººÃÔÉÑ· ªÔâÍâ¹¡Ô ¤é¹¾ºá͹µÔºÍ´ÕµéÒ¹äÇÃÑÊâ¤âùҵÑÇãËÁè·Õè¢Ö鹡ѺÀÙÁÔ¤ØéÁ¡Ñ¹¢Í§âÎʵì
ÁÕÈÑ¡ÂÀÒ¾à»ç¹ÂÒÃÑ¡ÉÒâä·ÕèÍÍ¡Ä·¸Ôìǧ¡ÇéÒ§ (Broad-spectrum Therapeutic Agent) ÊÓËÃѺâä·Õèà¡Ô´¨Ò¡äÇÃÑÊâ¤âùÒÊÒ¾ѹ¸ØìµèÒ§ æ ÃÇÁ¶Ö§àª×éÍ¡ÅÒ¾ѹ¸Øì -
ʶҺѹ¹Çѵ¡ÃÃÁªÕÇ¡ÒÃá¾·Âì ÊØ¢ÀÒ¾ áÅÐâÀª¹Ò¡ÒÃáËè§ªÒµÔ (National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN) àÁ×ͧÍÔºÒÃÒ¡Ô ¨Ñ§ËÇÑ´âÍ«Ò¡Ò ¼ÙéÍӹǡÒÃ: âªÔÎÔâà âÂ๴Ð) ÃèÇÁ¡Ñº ºÃÔÉÑ· ªÔâÍâ¹¡Ô á͹´ì ⤠¨Ó¡Ñ´ (Shionogi & Co., Ltd. á¢Ç§ªÙâÍ ¨Ñ§ËÇÑ´âÍ«Ò¡Ò »ÃиҹáÅЫÕÍÕâÍ: ÍÔ«ÒâÍÐ à·ªÔâáÔ) »ÃÐʺ¤ÇÒÁÊÓàÃç¨ã¹¡Òä鹾ºá͹µÔºÍ´ÕµéÒ¹äÇÃÑʵÑÇãËÁè·ÕèÍÍ¡Ä·¸ÔìµéÒ¹äÇÃÑÊâ¤âùÒÊÒ¾ѹ¸Øì¡ÅØèÁÍÒ¡Ò÷ҧà´Ô¹ËÒÂã¨à©Õº¾ÅѹÃعáç 2 (severe acute respiratory syndrome coronavirus 2: SARS-CoV-2) ÃÇÁ¶Ö§àª×éÍ¡ÅÒ¾ѹ¸Øì áÅÐÊÒ¾ѹ¸Øì¢Í§äÇÃÑÊâ¤âùҷÕèÁÕ¤ÇÒÁàª×èÍÁâ§ÍÂèÒ§ã¡ÅéªÔ´
á͹µÔºÍ´Õ·Õèà¾Ô觶١¤é¹¾ºãËÁè¹Õé¨Ñº¡Ñºâ»ÃµÕ¹Ë¹ÒÁ¢Í§äÇÃÑÊ·ÕèáÊ´§º¹¼ÔÇà«ÅÅì·ÕèµÔ´àª×éÍ á͹µÔºÍ´Õ·Õè¨Ñº¡Ñºâ»ÃµÕ¹´Ñ§¡ÅèÒÇʹѺʹع¡Òõͺʹͧ·Ò§ÀÙÁÔ¤ØéÁ¡Ñ¹¢Í§¼ÙéµÔ´àª×éÍà¾×èÍâ¨ÁµÕà«ÅÅì·ÕèµÔ´àª×éÍâ´ÂÇÔ¸Õ antibody-dependent cell-mediated cytotoxicity (ADCC) µÓá˹觷Õè¨Ñº¡Ñºâ»ÃµÕ¹ ËÃ×Íà;Ôâ·» (epitope) ¢Í§á͹µÔºÍ´Õ·Õè¤é¹¾ºãËÁè¹ÕéÍÂÙèã¹Êèǹ¨Óà¾ÒТͧâ¤Ã§ÊÃéҧ˹ÒÁ·ÕèÁÕ¤ÇÒÁäǵèÍ¡ÒáÅÒ¾ѹ¸ØìµèÓ «Öè§áµ¡µèÒ§¨Ò¡ÂÒá͹µÔºÍ´ÕÍ×è¹ æ ´Ñ§¹Ñé¹ á͹µÔºÍ´Õ¨Ö§·Ó»¯Ô¡ÔÃÔÂҡѺàª×éÍäÇÃÑÊ¡ÅÒ¾ѹ¸ØìµèÒ§ æ «Öè§ÃÇÁ¶Ö§ÊÒ¾ѹ¸ØìâÍÁÔ¤Ã͹ ÂÔè§ä»¡ÇèÒ¹Ñé¹ à¹×èͧ¨Ò¡â¤Ã§ÊÃéÒ§à;Ôâ·»·ÕèÁÕ¡ÒáÅÒ¾ѹ¸ØìàÅ硹éÍ ¾ºä´é·ÑèÇä»ã¹äÇÃÑÊâ¤âùÒÍ×è¹ æ ·Õèà¡ÕèÂÇ¢éͧ ¨Ö§¤Ò´ÇèÒá͹µÔºÍ´ÕµéÒ¹äÇÃÑÊ·Õèà¾Ô觤鹾ºãËÁè¹Õé¨ÐáÊ´§»ÃÐÊÔ·¸ÔÀҾ㹡Òõè͵éÒ¹äÇÃÑÊâ¤âùÒã¹Ç§¡ÇéÒ§ «Öè§ÃÇÁ¶Ö§ÊÒ¾ѹ¸Øì·ÕèÍÒ¨¨Ðà¡Ô´¢Öé¹ã¹Í¹Ò¤µ
ÊÓËÃѺ¡ÒÃãªé§Ò¹·Ò§¤ÅԹԡ㹻Ѩ¨ØºÑ¹ á͹µÔºÍ´Õ¤çÍ¡à·Å (antibody cocktails) áÅÐá͹µÔºÍ´Õ¡ÅØèÁźÅéҧķ¸Ôì (neutralizing antibody) µÑÇÍ×è¹ æ ¹Ñé¹ ¾Øè§à»éÒ¡ÒÃÃÑ¡ÉÒä»·Õè¼ÙéµÔ´àª×éÍäÁèÃعáç ã¹·Ò§µÃ§¡Ñ¹¢éÒÁ á͹µÔºÍ´Õ·Õèà¾Ô觤鹾ºãËÁèÍÒ¨àËÁÒÐÊÓËÃѺ¡ÒÃÃÑ¡ÉÒ¼Ùé»èÇ·ÕèÁÕ¤ÇÒÁàÊÕè§ÊÙ§ÇèÒ¨ÐÁÕÍÒ¡ÒâͧâäÃعáçÁÒ¡¡ÇèÒ ¹Í¡¨Ò¡¹Õé "á͹µÔºÍ´Õ·ÕèÁÕÄ·¸ÔìµéÒ¹äÇÃÑÊä´éÍÂèÒ§¡ÇéÒ§¢ÇÒ§" ¹èÒ¨ÐàËÁÒÐÍÂèÒ§ÂÔè§ÊÓËÃѺãªé㹡óթءà©Ô¹ ã¹ÂÒÁ·ÕèÍÒ¨ÁÕ¡ÒÃÃкҴ¢Í§âäâ¤âùÒäÇÃÑʪ¹Ô´ãËÁèà¡Ô´¢Öé¹ã¹Í¹Ò¤µ «Öè§ NIBIOHN ¨Ð´Óà¹Ô¹¡ÒÃÇÔ¨ÑÂà¾ÔèÁàµÔÁµèÍä»
¹ÓÃèͧ
[0] ´Ñª¹Õ¢éͤÇÒÁ
Go to full version